Companies related to Drug Conjugates

Science revives

Passion for Innovation. Compassion for Patients.

Putting science to work

BRINGING YOUR SCIENCE TO LIFE

We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis

Passion for Innovation. Compassion for Patients.

Biotech Consultancy Supporting Biopharmaceutical Development Globally

Where Empathy Meets Science to Accelerate Life Sciences Research

Pioneering the Development of Novel Payloads to Power the Next Generation of ADC for Cancer

MANAGING CYANOBACTERIA

Creating class-leading ADCs with enhanced tumor specificity

A Worldwide Pharmaceutical Export Management Company

Harnessing the power of a semi-synthetic organism with an expanded genetic alphabet to develop protein therapeutics

Building tomorrow's antibody-drug conjugates (ADCs)

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.

Discovery, optimisation and in-vivo production of a new generation of ADC payloads

We target the cells that drive fibrosis

RABCancer: A Predictive Platform for Antibody-Drug Conjugates. Follow us for insights into ADC trafficking & biomarkers

We target the cells that drive fibrosis

Your CDMO Partner for On-Time Process Development and cGMP Manufacturing.

Making way for breakthroughs

Integrated Chemistry Solution Provider

We develop advanced enzymatic solutions for toxicology, food safety, and genomics, fully designed and produced in-house.

Securing Life Sciences Supply Chain - Customized conjugation & formulation solutions. celares is now part of Biosynth.

Reimagining ADCs.